Perspective

Generic and therapeutic orphans

Published in: Volume 1 / Year 2012 / Issue 1
Author(s):
Page: 39-41

Abstract:¬† This commentary discusses the need to develop methods to ensure the availability of non-profitable, off-patent medicines to children and other populations. The history and some of the shortcomings of… Read More »

Myths, questions, facts about generic drugs in the EU

Published in: Volume 1 / Year 2012 / Issue 1
Author(s):
Page: 34-8

Abstract: Many generic drugs are now being prescribed and the trend is increasing. For example, in Austria, the number of all generics prescriptions has more than doubled from 11% in… Read More »

Current understanding, knowledge, and perception of biosimilars in a changing landscape of regulatory requirements

Author byline as per print journal: Andriy Krendyukov, MD, PhD; Marta Bakowska, BA (Hon), MPH; Dirk Schiller, PhD; Sanjay Singhvi, BSc (Hon), MBBS, MBA Introduction: Healthcare providers often lack familiarity… Read More »

Page 4 of 4 « Previous1 2 3 4
Go Back Print